Roussel Uclaf

Nicox Appoints Jean-Francois Labbé as Chairman of the Board of Directors

Retrieved on: 
Friday, July 29, 2022

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that Jean-Francois Labb, a Board member of Nicox SA, has been appointed as Chairman of the Nicox Board of Directors, effective July 28, 2022.

Key Points: 
  • Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that Jean-Francois Labb, a Board member of Nicox SA, has been appointed as Chairman of the Nicox Board of Directors, effective July 28, 2022.
  • We are pleased we will continue to benefit from his experience through his position on the Nicox Board.
  • The appointment of Jean-Francois Labb as Chairman of the Board completes the Board and management reorganization which began when I joined the company two months ago.
  • Jean-Franois Labb has served as a member of Nicox Board of Directors since June 2010 and has been the Chairman of the Audit Committee of Nicox since July 2013.

Nicox Announces a New Governance Structure

Retrieved on: 
Monday, May 16, 2022

Michele Garufi will remain as Board member of Nicox SA.

Key Points: 
  • Michele Garufi will remain as Board member of Nicox SA.
  • Jean-Franois Labb has served as a member of Nicox Board of Directors since 2010 and has been the Chairman of the Audit Committee of Nicox since 2013.
  • Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health.
  • Nicox disavows any obligation to correct or to update the information contained in analyst reports.